Neurocrine Biosciences (NBIX) Tops Q1 EPS by 29c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $162.75 +0.70%
EPS Growth %: -5.5%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -5.5%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.01), $0.29 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Stifel Reiterates Buy Rating on Neurocrine Bio. (NBIX)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
